US$ 26.00
tesamorelin ipamorelin combination evidence & CJC-1295 (Mod GRF 1-29) & (12mg) Tesamorelin + Ipamorelin (10/3 MG)
Description
Forty patients were randomized to inhale IS or HS 6% daily for 12 months and no important clinical superiority of HS over IS was identified

Data are expressed as mean SEM (n = 4)

J Endocrinol (2001) 171:8595

Exp Eye Res 177:197207

Metukuri et al., 2010
